GB Sciences Inc - ESG Rating & Company Profile powered by AI
This report of GB Sciences Inc incorporates data from across the internet and also from available filings by GB Sciences Inc. The article includes a questions and answers table on GB Sciences Inc. Complete Sustainability assessment of GB Sciences Inc are accessed by registering for free.
GB Sciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 8.0 and governance score of 5.3.
7.1
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
217 | Takara Bio Inc | 7.2 | High |
217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
224 | GB Sciences Inc | 7.1 | High |
224 | Celularity Inc | 7.1 | High |
224 | Bilcare Ltd | 7.1 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does GB Sciences Inc have an accelerator or VC vehicle to help deliver innovation?
Does GB Sciences Inc disclose current and historical energy intensity?
Does GB Sciences Inc report the average age of the workforce?
Does GB Sciences Inc reference operational or capital allocation in relation to climate change?
Does GB Sciences Inc disclose its ethnicity pay gap?
Does GB Sciences Inc disclose cybersecurity risks?
Does GB Sciences Inc offer flexible work?
Does GB Sciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does GB Sciences Inc disclose the number of employees in R&D functions?
Does GB Sciences Inc conduct supply chain audits?
Does GB Sciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does GB Sciences Inc conduct 360 degree staff reviews?
Does GB Sciences Inc disclose the individual responsible for D&I?
Does GB Sciences Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does GB Sciences Inc disclose current and / or historical scope 2 emissions?
Does GB Sciences Inc disclose water use targets?
Does GB Sciences Inc have careers partnerships with academic institutions?
Did GB Sciences Inc have a product recall in the last two years?
Does GB Sciences Inc disclose incidents of discrimination?
Does GB Sciences Inc allow for Work Councils/Collective Agreements to be formed?
Has GB Sciences Inc issued a profit warning in the past 24 months?
Does GB Sciences Inc disclose parental leave metrics?
Does GB Sciences Inc disclose climate scenario or pathway analysis?
Does GB Sciences Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does GB Sciences Inc disclose the pay ratio of women to men?
Does GB Sciences Inc support suppliers with sustainability related research and development?
Does GB Sciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does GB Sciences Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is GB Sciences Inc involved in embryonic stem cell research?
Does GB Sciences Inc disclose GHG and Air Emissions intensity?
Does GB Sciences Inc disclose its waste policy?
Does GB Sciences Inc report according to TCFD requirements?
Does GB Sciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does GB Sciences Inc disclose energy use targets?
Does GB Sciences Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does GB Sciences Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for GB Sciences Inc
These potential risks are based on the size, segment and geographies of the company.
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.